Brainstorm Cell Therapeutics Inc. (NASDAQ:BCLI) Q1 2023 Earnings Call Transcript May 15, 2023
Brainstorm Cell Therapeutics Inc. beats earnings expectations. Reported EPS is $-0.15, expectations were $-0.16.
Operator: Greetings, and welcome to the Brainstorm Cell Therapeutics First Quarter 2023 Earnings Call. At this time, participants are in a listen-only mode. As a reminder this call is being recorded. I’d now like to introduce your host for today’s call, Michael Wood of LifeSci Advisors....
